Keywords: coronary artery disease; percutaneous coronary intervention; stent thrombosisACS, acute coronary syndrome(s); ARC, Academic Research Consortium; BMS, bare-metal stent(s); DAPT, dual-antiplatelet therapy; DES, drug-eluting stent(s); GPI, glycoprotein IIb/I
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention : The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)
Keywords: clopidogrel; prasugrel; stent thrombosisACS, acute coronary syndrome(s); ADP, adenosine diphosphate; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention
Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation : An Individual Patient Data Pairwise and Network Meta-Analysis
Keywords: bleeding; major adverse cardiac event(s); stent thrombosisACS, acute coronary syndrome(s); CI, confidence interval; CrI, credible interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); HR, hazard ratio; MACE, major adverse cardiac event(s)
Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing : Impact of Prasugrel and High-Dose Clopidogrel
Keywords: bleeding; high-dose clopidogrel; high platelet reactivity; mortality; PCI; platelet function testing; prasugrel; stent thrombosisACS, acute coronary syndrome(s); BARC, Bleeding Academic Research Consortium; CI, confidence interval; HPR, high platelet reac
Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
Keywords: acute coronary syndrome(s); factor Xa inhibitor; rivaroxaban; stent thrombosisACS, acute coronary syndrome(s); DAPT, dual antiplatelet therapy; PCI, percutaneous coronary intervention
Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes
Keywords: acute coronary syndromes; risk score; stent thrombosisACS, acute coronary syndrome(s); GPI, glycoprotein IIb/IIIa inhibitor; NSTE-ACS, non–ST-segment elevation acute coronary syndrome; PCI, percutaneous coronary intervention; ST, stent thrombosis; STEMI,
Stent Thrombosis and Bleeding Complications After Implantation of Sirolimus-Eluting Coronary Stents in an Unselected Worldwide Population : A Report From the e-SELECT (Multi-Center Post-Market Surveillance) Registry
Keywords: antithrombotic therapy; bleeding complication; coronary stent; drug-eluting stent; sirolimus-eluting stent; stent thrombosisACS, acute coronary syndrome(s); DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); ESC, European Society of Cardiology;
Comparison of Everolimus- and Paclitaxel-Eluting Stents in Patients With Acute and Stable Coronary Syndromes : Pooled Results From the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolim
Keywords: acute coronary syndrome; drug-eluting stent(s); everolimus; paclitaxel; stent thrombosisACS, acute coronary syndrome(s); CAD, coronary artery disease; CI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio;